Hyperaldosteronism (Conn Syndrome) Summary

Networked: 3019 relevant articles (126 outcomes, 240 trials/studies) for this Disease

Key Drugs and Agents for Hyperaldosteronism

1. Aldosterone : 45 outcomes 106 studies in 1393 results : IBA
   
2. Spironolactone (Aldactone) : 17 outcomes 18 studies in 178 results : FDA 38 Generic
   
3. Renin : 14 outcomes 45 studies in 677 results : IBA
   
4. eplerenone (Inspra) : 5 outcomes 3 studies in 14 results : FDA 3 Generic
   
5. Potassium : 4 outcomes 13 studies in 216 results : IBA
   
6. Sodium : 4 outcomes 11 studies in 218 results : IBA
   
7. Dexamethasone (Maxidex) : 4 outcomes 8 studies in 112 results : FDA 77 Generic
   
8. Amiloride (Midamor) : 4 outcomes 3 studies in 30 results : FDA 11 Generic
   
9. Enalapril : 4 outcomes 3 studies in 8 results : FDA 28 Generic
   
10. Mineralocorticoid Receptors (Mineralocorticoid Receptor) : 4 outcomes 2 studies in 71 results : IBA
    

Diseases Related to Hyperaldosteronism

1. Hypertension (High Blood Pressure)
2. Adenoma (Adenomas)
3. Hyperplasia
4. Hypokalemia
5. Cushing Syndrome

Key Therapies for Hyperaldosteronism

1. Adrenalectomy : 37 outcomes 26 studies in 300 results
   
2. Oral Administration : 2 outcomes in 5 results
   
3. Drug Therapy (Chemotherapy) : 1 outcome in 9 results
   
4. Aftercare (After-Treatment) : 4 studies in 26 results
   
5. Sodium-Restricted Diet (Diet, Sodium Restricted) : 2 studies in 10 results